KeyBanc Maintains a 'Buy' on Tempur-Pedic (TPX); Raising Numbers After Positive Channel Checks

KeyBanc maintains a 'Buy' on Tempur-Pedic (NYSE: TPX) price target raised from $86 to $100.

KeyBanc analyst said, "Based on positive trends within the industry, we are raising our estimates for Tempur-Pedic. Our 1Q and 2Q EPS estimates remain at $0.85 (which is $0.02 above consensus) and $0.93, respectively. For the 3Q, our estimate goes to $1.17 from $1.16, and our 4Q estimate goes to $1.05 from $1.04. As such, our 2012 estimate goes to $4.00 from $3.98 (vs. consensus of $3.93). Additionally, our 2013 estimate goes to $4.75 from $4.60 (vs. consensus of $4.64)."

For an analyst ratings summary and ratings history on Tempur-Pedic click here. For more ratings news on Tempur-Pedic click here.

Shares of Tempur-Pedic closed at $84.12 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Freedom Broker Upgrades Lifeway Foods (LWAY) to Buy
• BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform